Evaluation of the Roche COBAS® TaqMan® HIV-1 test for quantifying HIV-1 RNA in infected cells and lymphoid tissue.

[1]  A. Kirn,et al.  Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[2]  M. Winkler,et al.  Evaluation of the new VERSANT HIV-1 RNA 1.0 Assay (kPCR) for quantitative detection of human immunodeficiency virus type 1 RNA. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[3]  Wendy Stevens,et al.  Evaluation of the Abbott m2000 RealTime Human Immunodeficiency Virus Type 1 (HIV-1) Assay for HIV Load Monitoring in South Africa Compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 Assays , 2009, Journal of Clinical Microbiology.

[4]  D. Hazuda,et al.  The Challenge of Finding a Cure for HIV Infection , 2009, Science.

[5]  B. Berkhout,et al.  Highly Sensitive Methods Based on Seminested Real-Time Reverse Transcription-PCR for Quantitation of Human Immunodeficiency Virus Type 1 Unspliced and Multiply Spliced RNA and Proviral DNA , 2008, Journal of Clinical Microbiology.

[6]  R. Siliciano,et al.  Experimental approaches to the study of HIV-1 latency , 2007, Nature Reviews Microbiology.

[7]  Michael D. George,et al.  Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1-Infected Patients Initiating Therapy during Primary or Chronic Infection , 2006, Journal of Virology.

[8]  P. Morlat,et al.  CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  R. Lempicki,et al.  Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Felipe García,et al.  Predictors of Tonsillar Tissue HIV-1 Viral Burden at Baseline and after 1 Year of Antiretroviral Therapy , 2002, Antiviral therapy.

[11]  S. Hammer,et al.  Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy. , 2003, The Journal of infectious diseases.

[12]  C. Crumpacker,et al.  Human immunodeficiency virus type 1 RNA in peripheral blood mononuclear cells of patients receiving prolonged highly active antiretroviral therapy. , 2001, The Journal of infectious diseases.

[13]  Felipe García,et al.  Lymphoid tissue viral burden and duration of viral suppression in plasma , 2001, AIDS.

[14]  O. Berg,et al.  Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization. , 2001, AIDS research and human retroviruses.

[15]  H. Günthard,et al.  Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection. , 2000, The American journal of pathology.

[16]  T. Chun,et al.  Latent reservoirs of HIV: obstacles to the eradication of virus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Fischer,et al.  Highly Sensitive Methods for Quantitation of Human Immunodeficiency Virus Type 1 RNA from Plasma, Cells, and Tissues , 1999, Journal of Clinical Microbiology.

[18]  T. Leitner,et al.  Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Boucher,et al.  Sensitive procedure for the amplification of HIV-1 RNA using a combined reverse-transcription and amplification reaction. , 1995, BioTechniques.

[20]  H. Gendelman,et al.  Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus , 1986, The Journal of experimental medicine.